Endotoxin removal by end-line filters

Author:

Vanhaecke E1,De Muynck C1,Remon J P1,Colardyn F1

Affiliation:

1. Laboratory for Pharmaceutical Microbiology and Hygiene, State University of Gent, Belgium.

Abstract

Four commonly used end-line filters, one with a charge-modified hydrophilic nylon filter (ELD96; Pall Biomedical Ltd., Portsmouth, United Kingdom), one with an unmodified nylon filter (FAE020; Pall Biomedical), and two with hydrophilic cellulose ester filters (Ivex-HP, Millipore Corp., Bedford, Mass.; Sterifix, Braun-Gelman, Brussels, Belgium), were evaluated for their endotoxin-removing capacity in saline and 5% glucose. Natural endotoxins derived from Escherichia coli 8739 and the lipopolysaccharide mutant Pseudomonas aeruginosa PA220-R2 and a purified E. coli serotype O111:B4 lipopolysaccharide preparation were used to challenge the four end-line filters. No endotoxin-removing capacity was observed for the Ivex-HP and Sterifix filters. Both the FAE020 and the ELD96 end-line filters showed excellent endotoxin-eliminating capacities in 5% glucose. Increasing the NaCl concentration in 5% glucose, however, greatly reduced the endotoxin-removing efficiency of especially the ELD96 filter for the purified E. coli lipopolysaccharide preparation. Obviously, both the nature of the endotoxin and the ionic strength of the solution had a major influence on the endotoxin end-line filtering efficiency.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Reference17 articles.

1. Chemical and ultrastructural comparison of endotoxins extracted from Salmonella minnesota wild type and R mutants;Amano K.;Microbiol. Immunol.,1984

2. Bacterial endotoxin retention by inline intravenous filters;Baumgartner T. G.;Am. J. Hosp. Pharm.,1986

3. Mitogenic effect of purified outer membrane proteins from Pseudomonas aeruginosa;Chen Y.;Infect. Immun.,1980

4. Binding of drugs to end-line filters: a study of four commonly administered drugs in intensive care units;De Muynck C.;J. Clin. Pharm. Therap.,1988

5. Care and cost-justification of final filtration;Harrigan C. A.;National Intravenous Therapy Association,1985

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3